Analysts foresee more revenue Carl Zeiss Meditec

On Monday the German Carl Zeiss Meditec will report its past quarters results. For this year the company, located in Jena revenue will be around 1.5 billion euros. This is according to the average of the analysts' estimates. This is rather significant more than 2019's revenue of 1.34 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2020

The analysts expect for 2020 a net profit of 175 million euros. The majority of the analysts expects for this year a profit per share of 2 euros. The price/earnings-ratio is then an extreme 69.35.

Analysts expect a dividend of 68 cents per share. Carl Zeiss Meditec 's dividend yield thus equals 0.49 percent. The average dividend yield of the pharmaceutical companies is a poor 0.16 percent.

Newest target prices around 92 euros

Based on the current number of outstanding shares Carl Zeiss Meditec 's market capitalization is 12.41 billion euros. The Carl Zeiss Meditec stock was the past 12 months quite volatile. Since last February the stock is 20 percent higher. This year the stock price moved between 68 and 140 euro.

Historical stock prices Carl Zeiss Meditec2007-2020

Click here for dividend Carl Zeiss Meditec. At 14.06 the stock trades 0.07 percent higher at 138.7 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.